Inpatient glycemic management in noncritically ill patients: Updated guidelines

Cleve Clin J Med. 2023 Oct 2;90(10):615-618. doi: 10.3949/ccjm.90a.23049.

Abstract

Hyperglycemia is common in hospitalized patients and is traditionally managed with scheduled and correctional doses of insulin. The authors present an overview of the latest (2022) guidelines from the Endocrine Society on inpatient hyperglycemia management in noncritically ill patients, which includes a role for newer diabetes technologies and nontraditional insulin and noninsulin therapies.

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus* / drug therapy
  • Humans
  • Hyperglycemia* / drug therapy
  • Hypoglycemic Agents / therapeutic use
  • Inpatients
  • Insulin / therapeutic use

Substances

  • Hypoglycemic Agents
  • Insulin
  • Blood Glucose